This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sl Vaxigen, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Sang Hee Sim
Introduction
Sang Hee Sim is a notable inventor based in Seongnam-si, South Korea. She has made significant strides in the field of vaccine development, particularly through her innovative work on vaccine adjuvants. Her contributions are vital in enhancing immune responses, which are crucial for effective vaccination.
Latest Patents
Sang Hee Sim holds a patent for a novel vaccine adjuvant. This adjuvant is designed to stimulate a T lymphocyte-specific immune response. It includes an IL-12 protein and an IL-21 protein as active ingredients, or alternatively, the polynucleotides encoding these proteins. This innovation is essential for improving vaccine efficacy.
Career Highlights
Sang Hee Sim is currently associated with Sl Vaxigen, Inc., where she continues to advance her research in immunology. Her work is characterized by a commitment to developing effective solutions for public health challenges. With 1 patent to her name, she exemplifies the spirit of innovation in the scientific community.
Collaborations
Some of her notable coworkers include Yong Bok Seo and Youngwoo Choi. Their collaborative efforts contribute to the ongoing research and development in the field of vaccine technology.
Conclusion
Sang Hee Sim's work in vaccine adjuvants represents a significant advancement in immunology. Her innovative approach and dedication to research are paving the way for more effective vaccines in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile